title: Integrative tumor board: metastatic renal cell carcinoma: medical oncology (II).
authors.affiliation: Senior Lecturer and Consultant Physician in Medical Oncology, Department of Oncology, St. George's Hospital Medical School, University of London, London, SW17 ORE, United Kingdom. hpandha@sghms.ac.uk
authors.forename: Hardev
authors.initials: H
authors.lastname: Pandha
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002292:Carcinoma, Renal Cell / Q000473:pathology* / Q000628:therapy*; D017024:Chemotherapy, Adjuvant; D005260:Female; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use; D007376:Interleukin-2 / Q000627:therapeutic use; D007680:Kidney Neoplasms / Q000473:pathology* / Q000628:therapy*; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009392:Nephrectomy; D011379:Prognosis
chemical_list: D016898:Interferon-alpha; D007376:Interleukin-2